Diabetes mellitus and rheumatoid arthritis are systemic diseases that are associated with an increased amount of CX3CL1 and CX3CR1, providing good evidence for their role in the chronic inflammatory process and pathogenesis of bone resorption. This evidence concerns the gene CX3CR1 and rheumatoid arthritis.